A rapid saliva test to assess protection against disease and monitor vaccination in low-middle income countries

点击翻译按钮获取中文摘要

Live saving childhood vaccinations fail to reach ~25 million children worldwide. As a result of the COVID-19 pandemic, many people across the world have missed out on essential vaccines, increasing those at risk of serious disease. Tetanus is a bacterial infection with a high death rate but is preventable with vaccination. Tetanus is one of the key vaccines given routinely but the amount of people receiving this vaccine has slipped back to lower levels seen many years ago. Eliminating tetanus has been an aim for over 20 years. This has been achieved in many countries but in low-middle income countries this disease is still a problem and continues to cause unnecessary deaths every year. It is important to monitor vaccination and understand how many people are protected against disease, but this can be challenging to do directly. Having information on immunity (protection from disease) is helpful to understand how well vaccination plans are working and help find individuals who are unprotected and need vaccination. However, testing immunity currently requires blood samples. Testing immunity in blood can be expensive and some countries are unable to do it. Also, not everyone wishes to have blood taken and taking blood from children is not desirable. We will develop a low-cost test that enables immunity to be tested easily, quickly, and without taking blood. The test uses saliva and is a lateral flow test, a type of test which is now well known to the public. The test shows if a person is/is not protected against tetanus within 15 minutes. If a person is unprotected against tetanus, they are also likely missing protection against other serious diseases and have not received all recommended vaccinations. The test can be used anywhere (outreach, community, clinic, hospital) and can improve access to immunity testing for those who currently are unable to do so. In this project we will develop our saliva test with help from an expert company. We will spend time trying various materials and ways to build the test to get the best invention. We are aiming to use as little plastic as possible in our test. We will also find out the easiest way to collect saliva to run the test. Then we will run lots of saliva samples on our test in a laboratory to check how well the test works. If the test works as well, it will then be sent to be included in a study in Malawi (a low-income country in Africa). In this study, we will see how well our test works in real-life and find out how suitable local people find the test. If successful, after the project we intend to try out the test in other countries to measure immunity among different communities, to improve vaccination monitoring and planning.